Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
|Synonyms||AUTS9 | c-Met | DFNB97 | HGFR | RCCP2|
|Gene Description||MET, MET proto-oncogene, receptor tyrosine kinase, is a receptor tyrosine kinase, which activates MAPK, PI3K/AKT, SRC, and STAT pathways to promote cell proliferation, invasion, and angiogenesis (PMID: 22128285). MET mutations, exon 14 skipping mutations (PMID: 31369639), and fusions have been identified in a variety of human cancers (PMID: 28603720), including lung cancer (PMID: 32273721), and MET amplification and/or overexpression has been reported in many solid tumors, including biliary tract cancer (PMID: 32085275), breast cancer (PMID: 31991499, PMID: 31892551, PMID: 32234363), NSCLC (PMID: 31832192), gastric cancer (PMID: 31499745), intrahepatic cholangiocarcinoma (PMID: 32089411), and gallbladder carcinoma (PMID: 31645095).|